The ESVS guidelines emphasize the need for aggressive secondary prevention, including lipid-lowering and antiplatelet therapies, in patients with carotid artery stenosis.
Answers are grounded in this paper and cite their sources.
Should prompt intensified lipid-lowering and antiplatelet use in carotid stenosis; extends prior consensus with updated ESVS synthesis.
Herein, we present the European Society for Vascular Surgery Guidelines pertinent to the secondary prevention of cerebrovascular events in patients with carotid artery stenosis including lipid lowering therapy, antiplatelet therapy and other risk factor modification. These recommendations are based on current evidence from clinical trials. There is a need for aggressive prevention treatment in patients with carotid artery disease. We also discuss the diagnosis and grading of carotid artery stenosis.
No takes yet. Share an insight, caveat, or question.
Liapis et al. (2010) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: